At first, we showed the relevance of IRE1 signaling in GBM from two independent cohorts (TCGA and GBMmark) and found that high IRE1 activity correlates with shorter patient survival and increased tumor infiltration by immune cells, increased tumor angiogenesis, and enhanced invasion/migration properties of the tumor cells (Fig 1). This evidence concerns the gene ERN1 and glioblastoma.